Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the impact of rapid infusion rituximab on the
incidence of infusion-related reactions in patients with Autoimmune Diseases.